Placental Stem Cell Therapy Shows Promise in Early Trial for Multiple Sclerosis
A controlled phase I trial published in Scientific Reports in May 2025 demonstrated that placental stem cell therapy appears to be safe and shows initial neuroprotective effects in patients with secondary-progressive multiple sclerosis (SPMS). The […]
